Stay updated on IPF/ILD-PRO Clinical Trial of Novel Therapy
Sign up to get notified when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.

Latest updates to the IPF/ILD-PRO Clinical Trial of Novel Therapy page
- Check4 days agoChange DetectedRemoved the text 'Interstitial lung disease 2' from the page. It appears to be a non-critical label and its removal does not affect the study details or enrollment information.SummaryDifference0.0%

- Check11 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2; no changes to study details or page behavior are evident.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedAdded the term 'Pulmonary fibrosis' to the page content as an extra keyword.SummaryDifference0.0%

- Check40 days agoChange DetectedCharlottesville, VA site added with its contact number. Baltimore, MD location and Maryland listing removed; phone number formatting updated from 2164450574 to 216-445-0574.SummaryDifference0.3%

- Check47 days agoChange DetectedNew investigators and contact details were added (e.g., Surya Olguin, Sally Suliman, Summer Zhu, Mary Strek, Mona Noroozi, etc.) and the contact/locations information was updated. The study locations now total 41.SummaryDifference3%

Stay in the know with updates to IPF/ILD-PRO Clinical Trial of Novel Therapy
Enter your email address, and we'll notify you when there's something new on the IPF/ILD-PRO Clinical Trial of Novel Therapy page.